본문 바로가기
KERD
논문KCI 등재

Epidemiological and Clinical Characteristics of Women Living with HIV in Korea

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Background While Korea maintains a low prevalence of human immunodeficiency virus (HIV), the number of newly diagnosed cases has been steadily rising, reaching approximately 1,000 annually in recent years. The 2022 annual report from the Korea Disease Control and Prevention Agency revealed that women living with HIV (WLWH) constitute 6.4% of the total confirmed people living with the HIV population, totaling 1,219 individuals. Despite this, only a few studies have focused on WLWH in Korea. This study aims to analyze the epidemiological and clinical characteristics of WLWH in Korea. Materials and Methods We retrospectively collected data by reviewing the medical records of all WLWH who visited 10 urban referral hospitals across Korea between January 2005 and May 2023. Results A total of 443 WLWH were enrolled in this study. The predominant risk exposure was heterosexual contact, with 235 (53%) participants either married or cohabiting with a male partner at their initial clinic visit. Among the participants, 334 (77.7%) were Korean, 27 (6.1%) were Southeast Asian, and 19 (4.3%) were African. Antiretroviral therapy was initiated by 404 WLWH (91.2%). We observed 118 pregnancies in WLWH following their HIV diagnosis, resulting in 78 live births (66.1%), 18 induced abortions (15.2%), 10 pre-viable fetal losses (8.5%), and four stillbirths (3.4%). Over a cumulative follow-up duration of 3,202.1 years, the incidence rates of breast and cervical cancers were both 2.18 per 1,000 person-years. Additionally, the incidence rates of pelvic inflammatory disease, cervical intraepithelial neoplasm (above grade II), and osteoporosis were 4.67, 11.21, and 13.39 per 1,000 patient-years, respectively. Conclusion This is the first multicenter study to investigate the clinical and epidemiological characteristics of WLWH in Korea. The incidence and prevalence of diseases in women, including breast cancer, cervical cancer, and chronic comorbidities, are high in WLWH in Korea; therefore, further research and efforts are needed to manage these diseases.

Abstract

Background While Korea maintains a low prevalence of human immunodeficiency virus (HIV), the number of newly diagnosed cases has been steadily rising, reaching approximately 1,000 annually in recent years. The 2022 annual report from the Korea Disease Control and Prevention Agency revealed that women living with HIV (WLWH) constitute 6.4% of the total confirmed people living with the HIV population, totaling 1,219 individuals. Despite this, only a few studies have focused on WLWH in Korea. This study aims to analyze the epidemiological and clinical characteristics of WLWH in Korea. Materials and Methods We retrospectively collected data by reviewing the medical records of all WLWH who visited 10 urban referral hospitals across Korea between January 2005 and May 2023. Results A total of 443 WLWH were enrolled in this study. The predominant risk exposure was heterosexual contact, with 235 (53%) participants either married or cohabiting with a male partner at their initial clinic visit. Among the participants, 334 (77.7%) were Korean, 27 (6.1%) were Southeast Asian, and 19 (4.3%) were African. Antiretroviral therapy was initiated by 404 WLWH (91.2%). We observed 118 pregnancies in WLWH following their HIV diagnosis, resulting in 78 live births (66.1%), 18 induced abortions (15.2%), 10 pre-viable fetal losses (8.5%), and four stillbirths (3.4%). Over a cumulative follow-up duration of 3,202.1 years, the incidence rates of breast and cervical cancers were both 2.18 per 1,000 person-years. Additionally, the incidence rates of pelvic inflammatory disease, cervical intraepithelial neoplasm (above grade II), and osteoporosis were 4.67, 11.21, and 13.39 per 1,000 patient-years, respectively. Conclusion This is the first multicenter study to investigate the clinical and epidemiological characteristics of WLWH in Korea. The incidence and prevalence of diseases in women, including breast cancer, cervical cancer, and chronic comorbidities, are high in WLWH in Korea; therefore, further research and efforts are needed to manage these diseases.

참고문헌 (26)

  1. Tariq S, "HIV and women's health : where are we now?", Womens Health(Lond), 18, pp.17455065221076341~ (2022)
  2. Curno MJ, "A systematic review of the inclusion(or exclusion)of women in HIV research : from clinical studies of antiretrovirals and vaccines to cure strategies", J Acquir Immune Defic Syndr, 71, pp.181~188 (2016)
  3. Annual report on the notified HIV, "AIDS in Korea, 2022", Korea Disease Control and Prevention Agency (KDCA), 2023
  4. Kim JM, "Epidemiology and clinical features of HIV infection", AIDS in Korea, 2003, pp.44, 363~370
  5. Yoo M, "Characteristics of recent HIV infection among individuals newly diagnosed as HIV-positive in South Korea(2008-2015)", Sci Rep, 12, pp.10515~ (2022)
  6. Choi Y, "Epidemiological characteristics of HIV infected Korean : Korea HIV", AIDS Cohort Study, 2019, pp.41, e2019037~
  7. Choi H, "Pregnancy rates and outcomes of HIV-infected women in Korea", J Korean Med Sci, 33, pp.e296~ (2018)
  8. Park EK, "Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea", J Korean Med Sci, 29, pp.32~37 (2014)
  9. Castro KG, "1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults", MMWR Recomm Rep, 41, pp.1~19 (1992)
  10. Chobanian AV, "National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure", Hypertension, 42, pp.1206~1252 (2003)
  11. American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 34(Suppl 1), pp.S62~S69 (2011)
  12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), "Third report of the National Cholesterol Education Program(NCEP)expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III)final report", Circulation, 106, pp.3143~3421 (2002)
  13. Kidney Disease : Improving Global Outcomes(KDIGO)CKD Work Group, "KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease", Kidney Int, 105(Suppl 4), pp.S117~S314 (2024)
  14. "Practice guidelines"[URL]
  15. "Clinical practice guidelines"[URL]
  16. Camacho PM, "American Association of Clinical Endocrinologists", American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update, 2020, pp.26, 1~46
  17. Workowski KA, "Sexually transmitted infections treatment guidelines, 2021", MMWR Recomm Rep, 70, pp.1~187 (2021)
  18. Kang MJ, "Cancer statistics in Korea : incidence, mortality, survival, and prevalence in 2020", Cancer Res Treat, 55, pp.385~399 (2023)
  19. Shisana O, "Does marital status matter in an HIV hyperendemic country? Findings from the 2012 South African national HIV prevalence, incidence and behaviour survey", AIDS Care, 28, pp.234~241 (2016)
  20. Choi JP, "HIV-related stigma reduction in the era of undetectable equals untransmittable : the South Korean perspective", Infect Chemother, 53, pp.661~675 (2021)
  21. Ghayda RA, "A review of pre-exposure prophylaxis adherence among female sex workers", Yonsei Med J, 61, pp.349~358 (2020)
  22. Goedert JJ, "Risk of breast, ovary, and uterine corpus cancers among 85, 268 women with AIDS", Br J Cancer, 95, pp.642~648 (2006)
  23. Amir H, "Breast cancer before and during the AIDS epidemic in women and men : a study of Tanzanian Cancer Registry Data 1968 to 1996", J Natl Med Assoc, 92, pp.301~305 (2000)
  24. Park B, "Cancer incidence among aults with HIV in a population-based cohort in Korea", JAMA Netw Open, 5, pp.e2224897~ (2022)
  25. Kim YC, "Survival trend of HIV", AIDS patients starting antiretroviral therapy in South Korea between 2001 and 2015, 2020, pp.61, 705~711
  26. Lee JA, "Identifying the unmet medical needs of HIV-positive subjects in Korea : results of a nationwide online survey", Infect Chemother, 55, pp.397~402 (2023)

관련 논문AI추천

Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort StudyAhn Kyoung Hwan, Choi Bo Youl, Choi Jungsoon, Choi Yunsu, Jun Yoon Hee, Kim Jung Ho, Kim Shin-Woo, Kim Soo Min, Kim Youn Jeong, Park Bo Young대한감염학회 · Infection and Chemotherapy2024 · 제56권 제4호Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study최보율, 최윤수, 최희정, Dae Won Park, Hyo Youl Kim, Joon Young Song, June Kim, Jun Young Choi, Mee-Kyung Kee, Myeongsu Yoo, Sang-Il Kim, Shin Woo Kim, Soo Min Kim, YoungHyun Shin, Youn Jeong Kim한국역학회 · Epidemiology and Health2019 · 제41권 Changing Trends in Pregnancy and Childbirth among Women Living with Human Immunodeficiency Virus at a Tertiary Hospital in Korea: A 28-Year Experience강진숙, 김기형, 김승철, 이선희, 이순옥, 이신원, 이정은대한감염학회 · Infection and Chemotherapy2019 · 제51권 제1호Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study성혜, 김상일, 김신우, 김윤정, 박대원, 송준영, Choi Bo Youl, Choi Jun-Yong, Choi Yunsu, Kim Jung Ho, Kim Minjeong, Park Boyoung대한감염학회 · Infection and Chemotherapy2023 · 제55권 제1호Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015기미경, 김민자, 김상일, 김수민, 김신우, 김용찬, 김효열, 박대원, 송준영, 안진영, 유명수, 최보율, 최윤수, 최준용, 최희정, 한명국연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제8호Comparison of Characteristics and Survival between Prospective and Retrospective Korea Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Cohort Studies기미경, 김상일, 김신우, 김준형, 송준영, 최보율, 최윤수, 최준용대한감염학회 · Infection and Chemotherapy2019 · 제51권 제4호

이 간행물의 다른 논문 (19건)